Drug profile · INN
dimenhydrinate
DIMENHYDRINATE
dimenhydrinate (DIMENHYDRINATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — dimenhydrinate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
dimenhydrinate (DIMENHYDRINATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dimenhydrinate?
dimenhydrinate (DIMENHYDRINATE) is a histamine h1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dimenhydrinate?
DIMENHYDRINATE is a marketed brand name for dimenhydrinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dimenhydrinate?
dimenhydrinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.